arrow_back_ios Back View more articles

Tower Cold Chain adds 2023 King’s Award for Innovation to last year’s Queen’s Award

Pharmaceutical container specialist Tower Cold Chain has been presented with its King’s Award for Enterprise by King Charles.

The Theale-based company won the award in the innovation category – adding to last year’s Queen’s Award for International Trade.

The firm, which develops and manufactures temperature-controlled containers for the transportation of life-science and biotech products, has earned award in recognition of its KTM container – a thermally insulated passive pallet shipping system, with a patented modular construction design.

Extensive investment enabled Tower to scale production of the KTM at the beginning of the decade, a period that also coincided with the outbreak of the Covid-19 pandemic, when the KTM was widely used by pharmaceutical manufacturers to ship vaccines globally.

A revolutionary contributor to the pharmaceutical logistics market, Tower’s passive systems consists of phase change materials (PCMs) and/or dry ice, intended to maintain the internal contents of the container within a specific temperature range for 120 hours, without any requirement for active control, electricity, or manual intervention.

The standard controlled temperatures are ambient (15 to 25°C), chilled (2 to 8°C), frozen (-15 to -25°C) and deep frozen (-60 to -80°C).

The KTM has filled a gap in the cold chain shipping market, with its design striking the optimum balance between volumetric efficiency, durability, and optimised weight.

Employing a modular construction of roto-moulded parts, this produced a lighter, more robust and cost-effective option – between five per cent and 30 per cent lighter than competitor products. This further improves the KTM’s sustainability credentials across all transport supply chains, offering a fully reusable, space-efficient solution.

“To win any King or Queen’s Award requires the highest standards, so for Tower Cold Chain to receive awards in two consecutive years is a fantastic achievement,” commented Niall Balfour, Tower Cold Chain’s CEO.

“With our industry-leading product, it is an incredible honour to receive such recognition for the KTM range as we continue to work with global pharmaceutical manufacturers, airlines and third-party logistics customers to deliver products to patients in a robust, reliable, reusable method.”

Tower Cold Chain accelerates growth with two new senior appointments

Read more

11.08.2023

Tower Cold Chain expands pharmaceutical corridors with new Singapore site

Read more

17.01.2023

Lord Lieutenant presents Tower Cold Chain with Queen’s Award

Read more

20.12.2022

Business Biscuit
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.